Fang Sui

xi'an jiaotong university

H指数:15

被引数:857

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CLCF1–ZIC5–CNTFR feedback loop drives cisplatin resistance in cervical squamous cell carcinoma

CLCF1–ZIC5–CNTFR反馈环路驱动宫颈鳞状细胞癌对顺铂的耐药性

Neoplasia

IF7.7

2026-07-250

OAAI

Chitosan Hydrogel-Stabilized Red Blood Cell Membrane Interface for Robust Electrochemical Sensing of Environmental Contaminants

壳聚糖水凝胶稳定的红细胞膜界面用于环境污染物的高效电化学传感

Journal of Bioresources and Bioproducts

IF13

2026-07-180

OAAI

Integrated DNA Repair Capacity and NER Gene Expression for Improving Risk Prediction in Head and Neck Squamous Cell Carcinoma

整合DNA修复能力和NER基因表达以改善头颈鳞状细胞癌的风险预测

Current Medical Science

IF1.5

2026-06-010

PRE

TET1 loss propels the development of hyperthyroidism by remodeling histone modifications of PAX8 promoter

TET1缺失通过重塑PAX8启动子的组蛋白修饰，推动甲状腺功能亢进症的发展。

Experimental & Molecular Medicine

IF12.9

2025-10-290

OAAI

EMC8 expression in head and neck squamous cell carcinoma: Implications for poor prognosis and deficient CD8+ T cell infiltration

EMC8在头颈鳞状细胞癌中的表达：对不良预后和CD8+ T细胞浸润不足的影响

Pathology - Research and Practice

IF0

2025-10-090

PRE

Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2024-05-250

OAAI

High expression of RTEL1 predicates worse progression in gliomas and promotes tumorigenesis through JNK/ELK1 cascade

BMC CANCER

IF3.4

2024-03-262

OAAI

MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma

BMC CANCER

IF3.4

2023-12-210

OAAI

Unraveling the differential perturbations of species-level functional profiling of gut microbiota among phases of methamphetamine-induced conditioned place preference

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2023-12-011

PRE

A Feedback Loop Involving Exosomal miR-146a and NG2 to Propel the Development and Progression of Hypothyroidism

THYROID

IF6.7

2023-08-162

PRE

Sorafenib decreases glycemia by impairing hepatic glucose metabolism

ENDOCRINE

IF2.9

2022-10-072

PRE

Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino) pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-07-0119

PREAI

Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy

治疗性肽自组装成刺激响应性簇状纳米杂化物用于癌症靶向治疗

ADVANCED FUNCTIONAL MATERIALS

IF19

2019-01-2366

OAAI

Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms

维生素c通过不同的机制通过ROS依赖性抑制MAPK/ERK和PI3K/AKT通路杀死甲状腺癌细胞

THERANOSTICS

IF13.3

2019-01-01139

OAAI

Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy

将丝鹿蛋白转化为自组装的可生物降解纳米平台，用于多靶向癌症治疗

ACS NANO

IF16

2018-10-1644

PREAI

Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch

CHEMISTRY OF MATERIALS

IF7

2018-09-2140

OAAI

Long non-coding RNAs in thyroid cancer: Biological functions and clinical significance

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2018-07-0139

PREAI

Proteasome inhibitor MG132 induces thyroid cancer cell apoptosis by modulating the activity of transcription factor FOXO3a

ENDOCRINE

IF2.9

2017-02-2021

PREAI

Increased expression of EHF via gene amplification contributes to the activation of HER family signaling and associates with poor survival in gastric cancer

CELL DEATH & DISEASE

IF9.6

2016-10-2748

OAAI

Positive Feedback Loops Between NrCAM and Major Signaling Pathways Contribute to Thyroid Tumorigenesis

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2016-10-1229

OAAI

Fang Sui

个人简介

教育背景

工作经历

荣誉奖项

研究方向